Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07122583 · ClinicalTrials.gov registry record · Phase 4
A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System
A Phase 4 study of Non-Surgical Fat Reduction, sponsored by AbbVie.
- Active
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT07122583 is a Phase 4 study of Non-Surgical Fat Reduction that is active but no longer recruiting, run by AbbVie. The registered enrollment target is 102 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07122583, a Phase 4 study of Non-Surgical Fat Reduction, is active but no longer recruiting, sponsored by AbbVie.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this protocol is the continued collection of data specific to the submental, inner thigh and back/bra body areas with CoolSculpting Elite. The study aims to collect post-market safety data while allowing for the collection of standardized photos and satisfaction questionnaires after treatment with commercial treatment parameters.
Conditions Studied
Interventions
- DEVICE CoolSculpting Elite System
Study Locations (1)
California
- Pacific Clinical Innovations - Vista
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2025-07-22 |
| Est. Completion | 2026-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07122583
The ClinicalTrials.gov registry entry for NCT07122583 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AbbVie, which has 526 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-Surgical Fat Reduction appearing as the primary indexed condition, and to 1 intervention - of which CoolSculpting Elite System is the first listed.
NCT07122583 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07122583 about?
NCT07122583 is a clinical study titled "A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System". The primary objective of this protocol is the continued collection of data specific to the submental, inner thigh and back/bra body areas with CoolSculpting Elite. The study aims to collect post-market safety data while allowing for the collection of standardized photos and satisfaction questionnair...
What is the current status of trial NCT07122583?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2025-07-22. Estimated completion is 2026-08.
What conditions does trial NCT07122583 study?
This clinical trial studies the following conditions: Non-Surgical Fat Reduction.
What interventions are being tested in trial NCT07122583?
The interventions under investigation include: CoolSculpting Elite System (DEVICE).
Who is sponsoring clinical trial NCT07122583?
This trial is sponsored by AbbVie, which has 526 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07122583 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.